Treatment Advances for Lymphoma Have Reduced Deaths by 70%
Treatment for Lymphoma
New state-of-the-art treatment advances for patients with follicular lymphoma, previously considered an incurable cancer, have reduced deaths in the first four years by 70 percent. A newly published study recommends that doctors carefully choose their patients' initial therapies because there may be significant differences in overall survival rates, according to researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center.
Scientists compared outcomes for 960 patients treated with three different regimens and survival rates vary from 91 percent for the newest treatments using monoclonal antibodies, to 69 percent for standard therapy.
"This is real evidence that the clinical advances we have